Phase 2 Trial Of LX4211 Demonstrates Significant And Rapid Improvements In Multiple Parameters In Type 2 Diabetic Patients
January 23rd, 2010 admin
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering breakthrough treatments for human disease, obtained positive results from a recently completed Phase 2 study of LX4211 in patients with type 2 diabetes mellitus…
Related Videos from Youtube
Type I diabetes doesn't win!Click here to donate: walk.jdrf.org
The Diabetic Epidemic and What You...Natural health expert Dr. Joseph Mercola talks about preventing and reversing diabetes. To know more about diabetes, visit articles.mercola.com
Diabetes Basics: What Is Diabetes?Learn and know the difference between Type 1 and Type 2 diabetes, as well as what happens to the body when you have diabetes.
What is Diabetes?dLife's Nicole Johnson talks about the different types of diabetes.
Related Posts
Oramed Pharmaceuticals Inc. (OTCBB: ORMP), a developer of alternative drug delivery systems, reported results for the recently completed Phase 2b non-FDA clinical trial of its flagship oral insulin capsule, ORMD-0801. The randomized, double-blind, placebo-controlled, multi-centered study conducted in South Africa evaluated responses of 29 Type 2 diabetes...
Arcion Therapeutics, a venture backed clinical stage biotechnology company developing topical therapies for chronic pain, announced top-line results from a successful Phase 2b double-blind, randomized, placebo-controlled clinical trial of its lead topical pain candidate, ARC-4558, in adult patients with painful diabetic neuropathy (PDN)…
Read More →
Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) and Bayer HealthCare AG announced that VEGF Trap-Eye showed positive results in a Phase 2 study in patients with diabetic macular edema (DME). The primary endpoint of the study, a statistically significant improvement in visual acuity over 24 weeks compared to the standard of care in DME, macular laser...
Bayer HealthCare AG and Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) announced that VEGF Trap-Eye showed positive results in a Phase II study in patients with Diabetic Macular Edema (DME). The primary endpoint of the study, a statistically significant improvement in visual acuity over 24 weeks compared to the standard of care in DME, macular laser...
CPEX Pharmaceuticals Inc. (NASDAQ: CPEX) reported preliminary results related to its Phase 2a proof-of-concept clinical trial of the Company’s nasal insulin product, Nasulin™…
Read More →
IRIDEX Corporation (Nasdaq: IRIX) announced the recent publication of a clinical study comparing results obtained in the treatment of diabetic macular edema (DME) using an IRIDEX laser and MicroPulse™ treatment protocol to those obtained using the recognized standard of care Early Treatment of Diabetic Retinopathy Study (ETDRS) laser protocol…
Read More →
Ipsen (Paris:IPN) (Euronext: FR0010259150; IPN), a global biopharmaceutical group, today announced that its partner Roche has disclosed results of the phase III T-emerge 3 study in patients with diabetes with taspoglutide, the first once weekly glucagon-like peptide-1 (GLP-1) analogue based on a human sequence. Taspoglutide originating from Ipsen’s...
Eyetech Inc. announced that positive results from a Phase 3 study of Macugen® (pegaptanib sodium) in patients with diabetic macular edema (DME) were presented at the World Ophthalmology Congress in Berlin…
Read More →
Tranzyme Pharma announced positive top-line results from a Phase 2, double-blind, placebo-controlled study evaluating TZP-102 capsules in diabetic patients with gastroparesis, a serious disorder characterized by the inability of the stomach to empty food efficiently. The study achieved a clinically meaningful and statistically significant improvement...
Ampio Pharmaceuticals, Inc. (OTC Bulletin Board: AMPE) announced the initiation of a Phase II clinical trial of Optina™ for the treatment of diabetic macular edema, an early stage of diabetic retinopathy. Diabetic macular edema is responsible for most vision loss in patients with diabetes mellitus…
Read More →
Related Tweets from Twitter
|
deexxii (Djhoan Cuaresma) : Yumyum! Ndi kaya ako magka diabetes neto?! ? thanks Muymuy! @justjefrox http://plixi.com/p/44089528.. Updated : 2010-09-09T11:58:44Z | Reply | View Tweet |
|
CatchMeNow_ (Nicol Suarez) : Nick, al principio se pregunt "Porque yo?" cuando supo que tenia diabetes...despues pens "Porque yo no?".. Updated : 2010-09-09T11:58:25Z | Reply | View Tweet |
|
2diabetes (2diabetes) : http://goo.gl/v62Z Canadian Diabetes Association launches campaign to address burden of diabetes in New Brunswick:... http://bit.ly/bod3xA.. Updated : 2010-09-09T11:57:53Z | Reply | View Tweet |
|
uni2ue (uni2ue) : Yes! Finally a TT I can go piggy meat on (ham) #fatstrippernames {diabetes}.. Updated : 2010-09-09T11:57:47Z | Reply | View Tweet |
|
AnnuityPayments (Annuity Payments) : Is it possible to get diabetes if you eat a lot of sugar but is still fit? http://bit.ly/bjSUw4.. Updated : 2010-09-09T11:55:52Z | Reply | View Tweet |
Related News from Digg
Leave a comment
| Trackback
